Published in Ann Neurol on November 13, 2015
Why Is there a Limit to the Changes in Myofilament Ca(2+)-Sensitivity Associated with Myopathy Causing Mutations? Front Physiol (2016) 0.76
The Importance of Intrinsically Disordered Segments of Cardiac Troponin in Modulating Function by Phosphorylation and Disease-Causing Mutations. Front Physiol (2016) 0.75
Regulation of contraction in striated muscle. Physiol Rev (2000) 9.40
Assays for actin sliding movement over myosin-coated surfaces. Methods Enzymol (1991) 3.53
Vertebrate tropomyosin: distribution, properties and function. J Muscle Res Cell Motil (2001) 2.38
GEnomes Management Application (GEM.app): a new software tool for large-scale collaborative genome analysis. Hum Mutat (2013) 2.23
Structure of the rigor actin-tropomyosin-myosin complex. Cell (2012) 2.14
Mutations in genes encoding fast-twitch contractile proteins cause distal arthrogryposis syndromes. Am J Hum Genet (2003) 2.11
Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure. J Mol Cell Cardiol (2006) 1.95
Tropomyosin position on F-actin revealed by EM reconstruction and computational chemistry. Biophys J (2011) 1.76
Thin filament length dysregulation contributes to muscle weakness in nemaline myopathy patients with nebulin deficiency. Hum Mol Genet (2009) 1.73
Contractile dysfunction of left ventricular cardiomyocytes in patients with pulmonary arterial hypertension. J Am Coll Cardiol (2014) 1.54
Calcium sensitizer agents: a new class of inotropic agents in the treatment of decompensated heart failure. Int J Cardiol (2005) 1.49
Mutations in TPM3 are a common cause of congenital fiber type disproportion. Ann Neurol (2008) 1.39
In vitro motility analysis of actin-tropomyosin regulation by troponin and calcium. The thin filament is switched as a single cooperative unit. J Biol Chem (1995) 1.38
Mutations in fast skeletal troponin I, troponin T, and beta-tropomyosin that cause distal arthrogryposis all increase contractile function. FASEB J (2006) 1.27
Mutations of the slow muscle alpha-tropomyosin gene, TPM3, are a rare cause of nemaline myopathy. Neurology (2002) 1.24
Effect of inorganic phosphate on the force and number of myosin cross-bridges during the isometric contraction of permeabilized muscle fibers from rabbit psoas. Biophys J (2008) 1.23
Altered myofilament function depresses force generation in patients with nebulin-based nemaline myopathy (NEM2). J Struct Biol (2009) 1.20
Structural basis for tropomyosin overlap in thin (actin) filaments and the generation of a molecular swivel by troponin-T. Proc Natl Acad Sci U S A (2008) 1.20
Changes in cross-bridge cycling underlie muscle weakness in patients with tropomyosin 3-based myopathy. Hum Mol Genet (2011) 1.16
Homozygosity for a nonsense mutation in the alpha-tropomyosin slow gene TPM3 in a patient with severe infantile nemaline myopathy. Neuromuscul Disord (1999) 1.10
A simple method for automatic tracking of actin filaments in the motility assay. J Muscle Res Cell Motil (1996) 1.07
A mutation in the alpha tropomyosin gene TPM3 associated with autosomal dominant nemaline myopathy NEM1. Nat Genet (1995) 1.05
Muscle histopathology in nebulin-related nemaline myopathy: ultrastrastructural findings correlated to disease severity and genotype. Acta Neuropathol Commun (2014) 1.04
Mutations in repeating structural motifs of tropomyosin cause gain of function in skeletal muscle myopathy patients. Hum Mol Genet (2013) 1.03
Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca²⁺ sensitivity. Cardiovasc Res (2013) 1.02
Myofibrillar Ca(2+) sensitivity is uncoupled from troponin I phosphorylation in hypertrophic obstructive cardiomyopathy due to abnormal troponin T. Cardiovasc Res (2012) 0.99
Identification of a founder mutation in TPM3 in nemaline myopathy patients of Turkish origin. Eur J Hum Genet (2008) 0.99
Congenital myopathy-causing tropomyosin mutations induce thin filament dysfunction via distinct physiological mechanisms. Hum Mol Genet (2012) 0.98
Novel deletion of lysine 7 expands the clinical, histopathological and genetic spectrum of TPM2-related myopathies. Brain (2013) 0.93
An atomic model of the tropomyosin cable on F-actin. Biophys J (2014) 0.91
Troponin activator augments muscle force in nemaline myopathy patients with nebulin mutations. J Med Genet (2013) 0.90
Tropomyosin movement on F-actin during muscle activation explained by energy landscapes. Arch Biochem Biophys (2014) 0.90
K7del is a common TPM2 gene mutation associated with nemaline myopathy and raised myofibre calcium sensitivity. Brain (2013) 0.90
TPM3 mutation in one of the original cases of cap disease. Neurology (2009) 0.89
Nemaline myopathy with stiffness and hypertonia associated with an ACTA1 mutation. Neurology (2012) 0.89
Expression and biological activity of Baculovirus generated wild-type human slow alpha tropomyosin and the Met9Arg mutant responsible for a dominant form of nemaline myopathy. Biochem Biophys Res Commun (2002) 0.89
Mutation update and genotype-phenotype correlations of novel and previously described mutations in TPM2 and TPM3 causing congenital myopathies. Hum Mutat (2014) 0.88
Skeletal muscle myopathy mutations at the actin tropomyosin interface that cause gain- or loss-of-function. J Muscle Res Cell Motil (2013) 0.87
Infantile muscular dystrophy in Canadian aboriginals is an αB-crystallinopathy. Ann Neurol (2011) 0.87
A TPM3 mutation causing cap myopathy. Neuromuscul Disord (2009) 0.85
Energy landscapes reveal the myopathic effects of tropomyosin mutations. Arch Biochem Biophys (2014) 0.80
Novel TPM3 mutation in a family with cap myopathy and review of the literature. Neuromuscul Disord (2013) 0.78
212th ENMC International Workshop:: Animal models of congenital muscular dystrophies, Naarden, The Netherlands, 29-31 May 2015. Neuromuscul Disord (2016) 0.78
The Sydney Heart Bank: improving translational research while eliminating or reducing the use of animal models of human heart disease. Biophys Rev (2017) 0.75